Kaisa Cui

13PUBLICATIONS
17CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 31, 2026
A Dually Nanobody-Engineered Milk-Derived Extracellular Vesicle Nanomedicine Targeting Tumour-Associated Macrophages and Cancer Cells for Cancer Therapy.

Zhiang Liu, Ying Chen, Yulin Cao

|Sep 12, 2025
FK228 reshapes tumor microenvironment to enhance anti-PD-L1 efficacy.

Liang Gong, Lu Tian, He Li

|Jul 11, 2025
Targeting ribosomes reprograms the tumour microenvironment and augments cancer immunotherapy.

Kaisa Cui, Bingxin Liu, Liang Gong

|Mar 06, 2025
The Hypoxia-Associated High-Risk Cell Subpopulation Distinctly Enhances the Progression of Glioma.

Quan Wan, Xuechao Wu, Jinxu Zhou

|Nov 29, 2024
Ferroptosis and the tumor microenvironment.

Kaisa Cui, Kang Wang, Zhaohui Huang

|Nov 25, 2023
SIRT5-mediated ME2 desuccinylation promotes cancer growth by enhancing mitochondrial respiration.

Peng Teng, Kaisa Cui, Surui Yao

Pageof 3

Frequent Collaborators

7 joint publications

Zhaohui Huang

2 joint publications

Qilin Li

2 joint publications

Youming Zhang

2 joint publications

Xiaojie Lu